{
    "title": "108_hr4781",
    "content": "The Act may be cited as the \"MMA Territorial Equity for Low-Income Individuals Act of 2004\" and aims to provide equitable treatment of residents of territories under the Medicare Prescription Drug Transitional Assistance Program. The Act, known as the \"MMA Territorial Equity for Low-Income Individuals Act of 2004,\" aims to ensure fair treatment for residents of territories in the Medicare Prescription Drug Transitional Assistance Program. Amendments include expanding coverage to Puerto Rico, the Virgin Islands, Guam, American Samoa, and the Commonwealth of the Northern Mariana Islands. The amendments made by the \"MMA Territorial Equity for Low-Income Individuals Act of 2004\" ensure that the poverty line for individuals in territories is the same as those in the continental United States. The effective date for these amendments is January 1, 2005. The \"MMA Territorial Equity for Low-Income Individuals Act of 2004\" ensures equitable treatment of residents of territories in premium and cost-sharing subsidies under the Medicare prescription drug program. The Social Security Act is amended to remove a subparagraph, and there are conforming amendments made to Section 1935 of the Act. These changes aim to ensure equitable treatment of residents of territories in Medicare prescription drug program subsidies. The Social Security Act is amended to remove subsections (f) and (g) of section 1108, as well as subsection (e). Additionally, section 1108(f) is amended by removing a reference to section 1935(e)(1)(B), and section 1860D-14(a)(3)(C) is amended by adding new language at the end. These changes aim to ensure fair treatment of territories in Medicare subsidies. The poverty line in territories will be the same as in the continental United States. The amendments will be effective as if included in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. The Institute of Medicine will report on Medicare beneficiaries in territories' access to prescription drugs. The Secretary of Health and Human Services requests the Institute of Medicine to study Medicare beneficiaries' access to prescription drugs in US territories during three periods: before the Medicare Prescription Drug Act, during the discount card program, and after the implementation of the prescription drug benefit. The study will include a report to relevant committees. The Secretary of Health and Human Services has requested the Institute of Medicine to study the cost of prescription drugs for Medicare beneficiaries in US territories and the health improvements resulting from the Medicare Prescription Drug Act of 2003. The report will be submitted to specific congressional committees."
}